Cohance Lifesciences Q1 FY27 results concall on Aug 5, 2026

Board & Shareholder Meetings View source PDF

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.0%1-day move

₹438.35

prior close

₹427.15

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0-0.4-0.4-0.6-3.0-2.8————————

Up moveDown movePending

AI summary

Cohance Lifesciences (formerly Suven Pharmaceuticals) will hold a conference call for investors and analysts on Wednesday, August 5, 2026 at 6:30 PM IST to discuss Q1 FY27 unaudited financial results for the quarter ended June 30, 2026. Results will be declared earlier the same day. The call starts with a management discussion, followed by an interactive Q&A. Dial-in and pre-registration details were shared.

Likely market impact

Lets investors hear management commentary on Q1 FY27 the same day results are out. Useful for gauging outlook and guidance cues from the leadership team.